Sabra Healthcare REIT (NASDAQ:SBRA) Reaches New 1-Year High – Here’s Why

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $21.52 and last traded at $21.5630, with a volume of 2164520 shares traded. The stock had previously closed at $20.00.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several recent analyst reports. Barclays began coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price objective for the company. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Citigroup downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and cut their price target for the company from $24.00 to $19.00 in a report on Monday, June 22nd. Raymond James Financial assumed coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, June 17th. They set an “underperform” rating for the company. Finally, Truist Financial raised shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a report on Wednesday, July 8th. Five research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Sabra Healthcare REIT has a consensus rating of “Hold” and an average price target of $21.45.

Sabra Healthcare REIT Trading Up 8.6%

The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The stock has a market cap of $5.48 billion, a P/E ratio of 34.50, a P/E/G ratio of 1.50 and a beta of 0.65. The stock has a 50-day moving average price of $19.59 and a 200-day moving average price of $19.76.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16. The company had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 5.5%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SBRA. Rothschild Investment LLC increased its stake in Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the last quarter. Strengthening Families & Communities LLC purchased a new position in shares of Sabra Healthcare REIT during the 4th quarter valued at about $29,000. Versant Capital Management Inc lifted its position in Sabra Healthcare REIT by 70.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 603 shares during the last quarter. Finally, Danske Bank A S purchased a new stake in Sabra Healthcare REIT in the third quarter worth approximately $30,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.